Cyclooxygenase-2 Inhibitors in Equine Practice

Compendium on Continuing Education for the Practicing Veterinarian

Volumn 21, Issue 6, 1999, Pages 548-550

  Blikslager, Anthony T ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0347120540     PISSN: 01931903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. MacAllister CG: Nonsteroidal antiinflammatory drugs: Their mechanism of action and clinical uses in horses. Vet Med 89(3): 237-240, 1994.
2. Karcher LF, Dill SG, Anderson WI, King JM: Right dorsal colitis. J Vet Intern Med 4(5):247-253, 1990.
3. 2. Am J Vet Res 46(8):1605-1615, 1985.
4. Robert A, Nezamis JE, Lancaster C, Hanchar AJ: Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury. Gastroenterology 77(3):433-443, 1979.
5. Mutoh H, Ota S, Hiraishi H, et al: Adaptive cytoprotection in cultured rat gastric mucus-producing cells: Role of mucus and prostaglandin synthesis. Dig Dis Sci 40(4): 872-878, 1995.
6. Robert A, Lancaster C, Davis JP, et al: Cytoprotection by prostaglandin occurs in spite of penetration of absolute ethanol into the gastric mucosa. Gastroenterology 88(1):328-333, 1985.
7. Schmidt KL, Henagan JM, Smith GS, et al: Prostaglandin cytoprotection against ethanol-induced gastric injury in the rat. Gastroenterology 88(3):649-659, 1985.
8. 2. Scand J Gastroenterol 16(5):647-652, 1981.
9. Konturek SJ, Robert A: Cytoprotection of canine gastric mucosa by prostacyclin: Possible mediation by increased mucosal blood flow. Digestion 25(3):155-163, 1982.
10. Lacy ER, Ito S: Microscopic analysis of ethanol damage to rat gastric mucosa after treatment with a prostaglandin. Gastroenterology 83(3):619-625, 1982.
11. Guth PH, Paulsen G, Nagata H: Histologic and microcirculatory changes in alcohol-induced gastric lesions in the rat: Effect of prostaglandin cytoprotection. Gastroenterology 87(5):1083-1090, 1984.
12. Tarnawski A, Hollander D, Stachura J, et al: Prostaglandin protection of the gastric mucosa against alcohol injury - A dynamic time-related process. Role of the mucosal proliferative zone. Gastroenterology 88(1): 334-352, 1985.
13. 2 have a synergistic role in rescuing intestinal barrier function in porcine ileum. J Clin Invest 100(8):1928-1933, 1997.
14. Zushi S, Shinomura Y, Kiyohara T, et al: Role of prostaglandins in intestinal epithelial restitution stimulated by growth factors. Am J Physiol 270(5):G757-G762, 1996.
15. 2 induces villous contraction in rats without affecting intestinal restitution. Gastroenterology 99(3):708-716, 1990.
16. Burrows GE: Therapeutic effect of phenylbutazone on experimental acute Escherichia coli endotoxemia in ponies. Am J Vet Res 42(1): 94-99, 1981.
17. Templeton CB, Bottoms GD, Fessler JF, et al: Endotoxin-induced hemodynamic and prostaglandin changes in ponies: Effects of flunixin meglumine, dexamethasone, and prednisolone. Circ Shock 23(4): 231-240, 1987.
18. Semrad SD, Hardee GE, Hardee MM, Moore JN: Low dose flunixin meglumine: Effects on eicosanoid production and clinical signs induced by experimental endotoxemia in horses. Equine Vet J 19(3): 201-206, 1987.
19. Moore JN, Garner HE, Shapland JE, Hatfield DG: Prevention of endotoxin-induced arterial hypoxemia and lactic acidosis with flunixin meglumine. Equine Vet J 13(2):95-98, 1981.
20. DeWitt D, Smith WL: Yes, but do they still get headaches? Cell 83(3):345-348, 1995.
21. Vane JR: Towards a better aspirin. Nature 367(6460):215-216, 1994.
22. Wallace JL: Nonsteroidal antiinflammatory drugs and gastroenteropathy: The second hundred years. Gastroenterology 112(3):1000-1016, 1997.
23. Budsberg S, Johnston S, Schwartz P: Evaluation of etodolac for the treatment of osteoarthritis of the hip in dogs: A prospective multicenter study. Vet Surg 25(5):420, 1996.
24. Mizuno H, Sakamoto C, Matsuda K, et al: Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology 112(2):387-397, 1997.
25. Wallace JL, Bak A, McKnight W, et al: Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: Implications for gastrointestinal toxicity. Gastroenterology 115(1):101-109, 1998.
26. Collins LG, Tyler DE: Phenylbutazone toxicosis in the horse: A clinical study. JAVMA 184(6):699-703, 1984.
27. Meschter CL, Gilbert M, Krook L, et al: The effects of phenylbutazone on the morphology and prostaglandin concentrations of the pyloric mucosa of the equine stomach. Vet Pathol 27(4):244-253, 1990.
28. Meschter CL, Gilbert M, Krook L, et al: The effects of phenylbutazone on the intestinal mucosa of the horse: A morphological, ultrastructural and biochemical study. Equine Vet J 22(4):255-263, 1990.
29. Cohen ND, Carter GK, Mealy RH, Taylor TS: Medical management of right dorsal colitis in 5 horses: A retrospective study (1987-1993). J Vet Intern Med 9(4):72-276, 1995.
30. Lees P, Creed RFS, Gerring EEL, et al: Biochemical and haematological effects of phenylbutazone in horses. Equine Vet J 15(2):158-167, 1983.
31. Seibert K, Zhang Y, Leahy K, et al: Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci USA 91(25):12013-12017, 1994.
32. Masferrer JL, Zweifel BS, Manning PT, et al: Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc Natl Acad Sci USA 91(8):3228-3232, 1994.
33. Zimmel DN, Blikslager AT: The role of cyclooxygenases in repair of ischemic-injured intestine. Proc 6th Equine Colic Res Symp: 16, 1998